Panax ginseng-derived vesicles
Anti-aging, firmness, antioxidant, and skin vitality formulation concepts.
- Source focus: Changbai Mountain ginseng root.
- Application fit: serum, ampoule, cream, and mask evaluation.
B2B formulation evaluation
Natural-origin vesicle raw materials for cosmetic R&D teams.
Ecyto Biotech develops and manufactures extracellular vesicle / phyto-vesicle raw materials for skincare formulation testing. Our current evaluation candidates cover ginseng, Ganoderma lucidum, Polygonum cuspidatum, and Gastrodia elata. We support personal care ingredient distributors, OEM/ODM laboratories, and brand R&D teams with sample guidance and product- and batch-specific technical review.
Candidate materials
Focused candidates for skincare concepts
Ganoderma lucidum-derived vesicles
Fungal-origin soothing, barrier-support, and early-aging formulation concepts.
- Source focus: Ganoderma lucidum mycelium and fruiting body.
- Application fit: sensitive-skin, calming, and barrier-care lines.
Polygonum cuspidatum-derived vesicles
Antioxidant care and oil/acne-prone skin formulation concepts.
- Source focus: Japanese knotweed root rich in resveratrol-related actives.
- Application fit: antioxidant, brightening, and acne-prone concepts.
Gastrodia elata-derived vesicles
Hydration, calming, antioxidant, and sensitive-skin formulation concepts.
- Source focus: mature Gastrodia elata tubers.
- Application fit: daily repair, dullness, and mild post-aesthetic concepts.
Other R&D candidate: Deer velvet antler-derived vesicles are animal-origin and are discussed only case by case after local regulatory and sourcing review. They are not part of the Southeast Asia plant-origin launch focus.
Current readiness
Candidate and documentation status
| Candidate | Evaluation format | INCI naming status | Technical file status |
|---|---|---|---|
| Panax ginseng-derived vesicles | Lyophilized evaluation sample | Application in preparation | Product- and batch-specific pack in preparation |
| Ganoderma lucidum-derived vesicles | Lyophilized evaluation sample | Application in preparation | Product- and batch-specific pack in preparation |
| Polygonum cuspidatum-derived vesicles | Lyophilized evaluation sample | Application in preparation | Product- and batch-specific pack in preparation |
| Gastrodia elata-derived vesicles | Lyophilized evaluation sample | Naming route under review | Product- and batch-specific pack in preparation |
Sample access and document release are subject to candidate selection, batch availability, customer qualification, and the intended cosmetic application.
Partner fit
Built for early technical evaluation
01
Lyophilized sample format for early formulation evaluation and logistics simplicity.
02
Reconstitution guidance, cool-down phase addition, dosage screening, and compatibility review.
03
Batch-specific technical documents shared as evaluation becomes relevant.
04
Support for concept positioning, sample protocols, and distributor/OEM technical discussions.
Quality & verification
Manufacturer identity and quality system
Ecyto Biotech is the overseas business brand of Shaanxi Yisaier Biotechnology Co., Ltd., which operates the in-house R&D and manufacturing platform supporting our B2B material evaluations.
Management system
ISO 9001:2015 / GB/T 19001-2016
Certificate number
041026Q00515R101
Validity
05 Jun 2026 to 01 Jun 2029
Certified organization
Shaanxi Yisaier Biotechnology Co., Ltd.
Certified scope
Large-scale extraction and preparation of sterile exosome raw materials (for technical R&D only, excluding clinical applications).
This is quality management system certification. Product naming, cosmetic regulatory review, and market-specific compliance are handled separately.
View current ISO certificateRegulatory positioning
Clear boundaries for early-stage B2B review
INCI naming route
INCI naming applications for ginseng, Ganoderma lucidum, and Polygonum cuspidatum vesicle candidates are being prepared. INCI naming is an ingredient-name assignment process, not a product approval.
Cosmetic-only communication
Public materials avoid human-source, stem-cell therapy, medical treatment, wound-healing, or drug-grade claims.
Technical review package
Product- and batch-specific TDS, SDS, COA, NTA/TEM data, safety brief, and sample protocols are being assembled and will be released when applicable during NDA or qualified technical review.
Evaluation package
Documents for R&D and sourcing review
Technical introduction
Preliminary one-page B2B formulation overview
Sample testing plan
Suggested sample handling and formulation evaluation flow
Further documents
Product- and batch-specific TDS, SDS, COA, NTA/TEM data, and safety materials are in preparation and will be released when applicable during qualified technical review.
Contact
Discuss a sample evaluation or distributor fit.
For OEM/ODM laboratories, personal care ingredient distributors, and skincare R&D teams, please contact our overseas business team.
Runji Yang
General Manager, Overseas Business
runji.yang@ecytobiotech.com
ecytobiotech.com
LinkedIn company page
Floors 1-4, Building 3, South of East-West No.4 Road in Chang'an Communication Industrial Park, 140 meters east of the intersection of Runfeng Road and Qianyuan Road, High-tech Zone, Xi'an City, Shaanxi Province, China.